Ustimenko Y. A., Mazur Iu. Iu.

POTENTIAL CORRELATION OF VASPIN EXPRESSION WITH RESISTANCE AND COMBINED EXERCISES IN WOMEN WITH THE METABOLIC SYNDROME

---

Show/Download

About the author:

Ustimenko Y. A., Mazur Iu. Iu.

Heading:

LITERATURE REVIEWS

Type of article:

Scientific article

Annotation:

Metabolic syndrome is not only a cluster of symptoms that impair the quality of life, but also acts as a predictor of deadly diseases. The study of mechanisms for overcoming disease states associated with metabolic syndrome is aimed not only at the humanistic component, but also at reducing the financial burden on the global health system. One of the blood metabolites important in preventing the progress of cardiovascular disease and type 2 diabetes in the presence of excess body weight is vaspin. The aim of the study to analyze and systematize the modern scientific literature on the world statistics of diseases that are part of the metabolic syndrome and to study the effect of various types of physical exertion on the expression of vaspin, which reduces the risks of development of cardiovascular diseases and type 2 diabetes due to the positive effect on biomarkers of inflammatory reactions and energy metabolism in the body. The available modern scientific base on the issue of vaspin expression under the influence of various types of physical exertion does not currently give comprehensive answers what actualizes the emergence of new studies.

Tags:

Bibliography:

1. World Health Organization. Cardiovascular diseases (CVDs). Geneva: WHO; 2021. Available from: https://www.who.int/news-room/factsheets/detail/ cardiovascular-diseases-(cvds)https://diabetesatlas.org/.
2. Ambroselli D, Masciulli F, Romano E, Catanzaro G, Besharat ZM, Massari MC, et al. Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation. Nutr Rev. 2017;75(5):307-326. DOI: 10.1093/nutrit/nux014.
3. Myers J, Kokkinos P, Nyelin E. Physical Activity, Cardiorespiratory Fitness, and the Metabolic Syndrome. Nutrients. 2019;11(7):1652. DOI: 10.3390/nu11071652.
4. Alberti KGMM, Zimmet PZ. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Provisional Report of a WHO Consultation. Diabet. Med. 1998;15:539-553. DOI: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S.
5. Balkau B, Charles MA. Comment on the Provisional Report from the WHO Consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med.1999;16:442-443.
6. Saladini F, Palatini P. Arterial Distensibility, Physical Activity, and the Metabolic Syndrome. Curr Hypertens Rep. 2018;20(5):39. DOI: 10.1007/s11906-018-0837-3.
7. Pedersen BK. Anti-inflammatory effects of exercise: role in diabetes and cardiovascular disease. Eur J Clin Invest. 2017;47(8):600-611. DOI: 10.1111/eci.12781.
8.  Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; And International Association for the Study of Obesity. Circulation. 2009;120:1640-1645.
9. Levesque J, Lamarche B. The Metabolic Syndrome: Definitions, Prevalence and Management. J. Nutr. Nutr. 2008;1:100-108. DOI: 10.1159/000112457.
10. Kassi E, Pervanidou P, Kaltsas G, Chrousos G. Metabolic syndrome: definitions and controversies. BMC Med. 2011;9:48. DOI: 10.1186/1741-7015-9-48.
11. Hida K, Wada J, Eguchi J, Zhang H, Baba M, Seida A, et al. Visceral adipose tissue-derived serine protease inhibitor: a unique insulinsensitizing adipocytokine in obesity. Proc Natl Acad Sci U S A. 2005;102(30):10610-5. DOI: 10.1073/pnas.0504703102.
12. Saad MJA, Santos A, Prada PO. Linking Gut Microbiota and Inflammation to Obesity and Insulin Resistance. Physiology (Bethesda). 2016;31:283-293. DOI: 10.1152/physiol.00041.2015.
13. Heiker JT. Vaspin (serpinA12) in obesity, insulin resistance, and inflammation. J Pept Sci. 2014;20(5):299-306. DOI: 10.1002/psc.2621.
14. Mm WQ, Fan J, Khor S, Song M, Hong W, Dai X. Serum vaspin levels and vaspin mRNA expression in subcutaneous adipose tissue in women with gestational diabetes mellitus. Eur J Obstet Gynecol Reprod Biol. 2014;182:98-101. DOI: 10.1016/j.ejogrb.2014.09.008.
15. Recinella L, Orlando G, Ferrante C, Chiavaroli A, Brunetti L, Leone S. Adipokines: New Potential Therapeutic Target for Obesity and Metabolic, Rheumatic, and Cardiovascular Diseases. Front Physiol. 2020;11:578966. DOI: 10.3389/fphys.2020.578966.
16. Feng R, Li Y, Wang C, Luo C, Liu L, Chuo F, et al. Higher vaspin levels in subjects with obesity and type 2 diabetes mellitus: a metaanalysis. Diabetes Res Clin Pract. 2014;106(1):88-94. DOI: 10.1016/j.diabres.2014.07.026.
17. Yan M, Su B, Peng W, Li L, Li H, Zhuang J, et al. Association of serum vaspin and adiponectin levels with renal function in patients with or without type 2 diabetes mellitus. J Diabetes Res. 2014;2014:868732. DOI: 10.1155/2014/868732.
18. Yang W, Li Y, Tian T, Wang L. Serum Vaspin Concentration in Elderly Type 2 Diabetes Mellitus Patients with Differing Body Mass Index: A Cross-Sectional Study. Biomed Res Int. 2017;2017:4875026. DOI: 10.1155/2017/4875026.
19. Xu X, Wen J, Lu Y, Ji H, Zhuang J, Su Y, et al. Impact of age on plasma vaspin concentration in a group of normal Chinese people. J Endocrinol Invest. 2017;40(2):143-151. DOI: 10.1007/s40618-016-0533-6.
20. Jian W, Peng W, Xiao S, Li H, Jin J, Qin L, et al. Role of serum vaspin in progression of type 2 diabetes: a 2-year cohort study. PLoS One. 2014;9(4):e94763. DOI: 10.1371/journal.pone.0094763.
21. Yang W, Li Y, Tian T, Wang L, Lee P, Hua Q. Serum vaspin concentration in elderly patients with type 2 diabetes mellitus and macrovascular complications. BMC Endocr Disord. 2017;17(1):67. DOI: 10.1186/s12902-017-0216-0.
22. Hida K, Wada J, Eguchi J, Zhang H, Baba M, Seida A, et al. Visceral adipose tissue-derived serine protease inhibitor: a unique insulinsensitizing adipocytokine in obesity. Proc Natl Acad Sci U S A. 2005;102(30):10610-5. DOI: 10.1073/pnas.0504703102.
23. Auguet T, Quintero Y, Riesco D, Morancho B, Terra X, Crescenti A, et al. New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women. BMC Med Genet. 2011;12:60. DOI: 10.1186/1471-2350-12-60.
24. Pilarski Ł, Pelczyńska M, Koperska A, Seraszek-Jaros A, Szulińska M, Bogdański P. Association of Serum Vaspin Concentration with Metabolic Disorders in Obese Individuals. Biomolecules. 2023;13(3):508. DOI: 10.3390/biom13030508.
25. Ke X, Hao Y, Li B, Zou J, Li X, Wei C, et al. Vaspin Prevents Tumor Necrosis Factor-α-Induced Apoptosis in Cardiomyocytes by Promoting Autophagy. J Cardiovasc Pharmacol. 2018;77(5):257-267. DOI: 10.1097/FJC.0000000000000562.
26. Dwipayana IMP, Semadi IMS, Gotera W, Saraswati MR, Suastika K. Vaspin in Developing Obesity (Vande-Ob); the Correlation of Waist Circumference and Visceral Fat Percentage with Vaspin Levels in Patients with Type II Diabetes Mellitus. Open Access Maced J Med Sci. 2019;7(1):50-52. DOI: 10.3889/oamjms.2019.011.
27. Miyatake N, Wada J, Nakatsuka A, Sakano N, Teshigawara S, Miyachi M, et al. Serum vaspin levels are associated with physical activity or physical fitness in Japanese: a pilot study. Environ Health Prev Med. 2014;19(3):200-6. DOI: 10.1007/s12199-013-0375-1.

Publication of the article:

«Bulletin of problems biology and medicine», 2024 Issue 4, 175, 140-145 pages, index UDC 796.015.6+572.023-055.2:612.015.3

DOI:

10.29254/2077-4214-2024-4-175-140-145